ARTICLE | Company News
NPS, AstraZeneca in CNS deal
March 28, 2001 8:00 AM UTC
NPS (NPSP; TSE:NX) and AZN will develop small molecules to treat central nervous system (CNS) disorders. Under the agreement, AZN received a license to NPSP's technology related to metabotropic glutam...